i-Base home
Search Menu
  • Home
  • HTB
  • 2019
  • June

June 2019

Contents

Editorial

  • HTB 19 June 2019: vol 20 no 7 – PK Workshop, UK PrEP £17.50 a bottle

Conference reports

  • 20th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs
  • Efavirenz 600 mg exposure appears sufficient with high-dose daily rifapentine
  • Drug-drug interactions between efavirenz and levonorgestrel influenced by genetic variants 
  • Infant dolutegravir exposure through placental and breastmilk transfer  
  • Antiretroviral pharmacokinetics in pregnancy: update from IMPAACT P1026s

Treatment access

  • Two pints of lager and a packet of PrEP please: London price for HIV PrEP drops to £17.50
  • Activists challenge block to generic PrEP and current US price of TDF/FTC

TB coinfection

  • FDA advisory committee votes favorably on use of pretomanid with bedaquiline and linezolid for drug-resistant TB

On the web

  • HIV criminalisation: report from HIV Justice Network
  • Venezuela: report on health and humanitarian emergency

PDFs

  • 19 June 2019 vol 20 no 7
  • HTB RSS

Early access

  • US CDC updated guidelines on PEP (May 2025) 10 May 2025
  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook